Dual Guidance in Regional Anesthesia

• Sponsor: Charite University, Berlin, Germany (Other)
• Overall Status: Completed
• CT.gov ID: NCT03383770
• Collaborator: (none)
• Enrollment: 40
• Location: 1
• Arms: 2
• Actual Duration (Months): 19.3
• Patients Per Site Per Month: 2.1

Study Details

Study Description

Brief Summary

Regional anaesthesia is a frequently used procedure. Currently, blockades are increasingly carried out without nerve stimulation. The risk of nerve lesion is about 3 %. Industrial efforts frequently referred to ultrasound optimisation of the regional anaesthesia cannula. In order to optimise patient safety, the benefit of both procedures (stimulation and ultrasound) should be combined and both procedures optimised. In this study, the influence of the needle electrode size on the stimulability of the nerve ischiadicus should be determined.

Condition or Disease	Intervention/Treatment	Phase
Anesthesia, Local; Anesthesia; Anesthesia; Adverse Effect	Procedure: Regional Anesthesia Touhy; Procedure: Regional Anesthesia Facet	N/A

Detailed Description

There are various methods of performing regional anesthesia. In recent years, the focus has been on ultrasound-supported regional anaesthesia, and the stimulation methods that were often used in the past were no longer used or used less frequently. The combination of both methods may be an additional safety aspect and can contribute to an improved blocking quality. In addition to the best possible ultrasound quality, an optimal stimulation quality is also required. The investigators plan to carry out dual-guidance blockages of the ischiadic nerve with various regional anaesthesia needles (manufacturer of the used needles: Pajunk Medical Produkte GmbH, Geisingen, Germany; Teleflex Medical GmbH, Kernen, Germany). All regional anaesthesia cannulae are approved for the planned blockades of humans in Germany.

Study Design

• Study Type: Interventional
• Actual Enrollment: 40 participants
• Allocation: Randomized
• Intervention Model: Parallel Assignment
• Intervention Model Description: The selection of the puncture cannula for regional anaesthesia is not up to the performing anaesthetist, as is usual in the clinical standard, but is made randomly on the basis of a random list. The blockade is carried out by two anaesthetists experienced in regional anaesthesia, who have the principle of dual control. The ultrasound image acquired during the blockade is recorded in the form of an ultrasound video for subsequent evaluation. The recorded ultrasound videos are stored pseudonymously on the server of the Klinik für Anästhesiologie m. S. operativ Intensivmedizin reported to the data protection department.The selection of the puncture cannula for regional anaesthesia is not up to the performing anaesthetist, as is usual in the clinical standard, but is made randomly on the basis of a random list. The blockade is carried out by two anaesthetists experienced in regional anaesthesia, who have the principle of dual control. The ultrasound image acquired during the blockade is recorded in the form of an ultrasound video for subsequent evaluation. The recorded ultrasound videos are stored pseudonymously on the server of the Klinik für Anästhesiologie m. S. operativ Intensivmedizin reported to the data protection department.
• Masking: Single (Participant)
• Primary Purpose: Treatment
• Official Title: Dual Guidance in Regional Anesthesia - Prospective Randomized Study of Needle-nerve Distance in Different Cannulas for Regional Nerve Blockade
• Actual Study Start Date: Feb 5, 2018
• Actual Primary Completion Date: Sep 15, 2019
• Actual Study Completion Date: Sep 15, 2019

Arms and Interventions

Arm	Intervention/Treatment
Active Comparator: Tuohy After a careful disinfection of the puncture site, under sterile conditions and under ultrasonographic control with the application of nerve stimulation (settings: stimulation current primary 2.0 mA with stepwise reduction over 1.0 mA to 0.5 mA, pulse width 0.1 ms, pulse frequency 2 Hz) of the N. ischiadicus blocked by 20 ml ropivacaine 0.75 %. (electrical nerve stimulation and ultrasound) If no motor response can be triggered by stimulation, the closest possible needle-nerve distance is generated at a pulse strength of 1mA and regional anesthesia is performed. (protective nerve stimulation) Subsequently, the transplantation into the supine position and the further procedure specific to the operation (use of other regional procedures in combination or general anaesthesia). A tuohy needle is used.	Procedure: Regional Anesthesia Touhy; The patients receive the planned anaesthesia procedure according to the procedure to be performed. Only nerve blockages are carried out, which are considered to be analgesic useful for the planned operations on the basis of typical nerve courses. A touhy cannula is used.
Active Comparator: Facet After a careful disinfection of the puncture site, under sterile conditions and under ultrasonographic control with the application of nerve stimulation (settings: stimulation current primary 2.0 mA with stepwise reduction over 1.0 mA to 0.5 mA, pulse width 0.1 ms, pulse frequency 2 Hz) of the N. ischiadicus blocked by 20 ml ropivacaine 0.75 %. (electrical nerve stimulation and ultrasound) If no motor response can be triggered by stimulation, the closest possible needle-nerve distance is generated at a pulse strength of 1mA and regional anesthesia is performed. (protective nerve stimulation) Subsequently, the transplantation into the supine position and the further procedure specific to the operation (use of other regional procedures in combination or general anaesthesia). A facet needle is used.	Procedure: Regional Anesthesia Facet; The patients receive the planned anaesthesia procedure according to the procedure to be performed. Only nerve blockages are carried out, which are considered to be analgesic useful for the planned operations on the basis of typical nerve courses. A facet cannula is used.

Outcome Measures

Primary Outcome Measures

1. Ultrasound distance [duration of blockade, an average of 15 minutes]

   Ultrasound-based measurement of needle-nerve distance during the application of the regional anesthesia of the N. ischiadicus during infragluteal access.

Secondary Outcome Measures

1. Visibility_1 [duration of blockade, an average of 15 minutes]

   Ultrasound visibility of needle

2. Visibility_2 [duration of blockade, an average of 15 minutes]

   Ultrasound visibility of nerve

3. Impedance [duration of blockade, an average of 15 minutes]

   Impedance measured by nerve stimulator while progressing the needle

4. Effect_motor [duration of surgery and recovery unit, an average of 120 minutes]

   Effectiveness of the motor blockade measured by possible movement of the foot

5. Effect_sensoric [duration of surgery and recovery unit, an average of 120 minutes]

   Effectiveness of the blockade measured by temperature sensibility testing on the food

Other Outcome Measures

1. Impedance_Change [duration of blockade, an average of 15 minutes]

   Changes in impedance measurement while blockade

2. Complications [duration of surgery and recovery unit, an average of 120 minutes]

   Occurence of complications of regional anesthesia

3. Contact [duration of blockade, an average of 15 minutes]

   Number of Needle-Nerve-Contacts by Ultrasound-measurement

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years and Older
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion Criteria:

• Presence of the written declaration of consent

• Age of at least 18 years

• No participation in another intervention study during participation

Exclusion Criteria:

• present contraindication for the application of regional anesthesia and nerve stimulation

• Cardiac pacemaker/AICD (Automated internal cardioverter defibrillator) carrier

• Known allergies to used medicines

• Patients under 18 years of age

• Ineligible patients

• Missing consent

• Pregnancy/nursing patients

• Classification of patients into class 4 or higher status according to the American Society of Anesthesiologists

• Existing nerve damage in the target area

• Medically treated diabetes mellitus, alcohol abuse or alcohol abuse in the patient's history (using AUDIT)

• Visibility score of the nerve of 3 or more

• Participation in another intervention study during participation

• Accommodation in an institution on the basis of a court or administrative order

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Charité - Universitätsmedizin Berlin Campus Charité Mitte	Berlin	Deutschland	Germany	10115

Sponsors and Collaborators

• Charite University, Berlin, Germany

Investigators

• Principal Investigator: Jürgen Birnbaum, MD, PhD, Charite University, Berlin, Germany

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Jurgen Birnbaum, PD Dr. med.; Consultant Anaesthesiologist, Charite University, Berlin, Germany
• ClinicalTrials.gov Identifier: NCT03383770
• Other Study ID Numbers: DUAL
• First Posted: Dec 26, 2017
• Last Update Posted: Feb 4, 2022
• Last Verified: Jan 1, 2022

• Individual Participant Data (IPD) Sharing Statement: No
• Plan to Share IPD: No
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Additional relevant MeSH terms: Anesthetics

Study Results

No Results Posted as of Feb 4, 2022